Assessing HIPAA Risks During the M&A Due Diligence Process

Jon Moore, Chief Risk Officer and Senior Vice President of Consulting Services, Clearwater, speaks with Vanessa Burrows, Counsel, Simpson Thacher & Bartlett LLP, and Wendi Wright, Senior Director of Privacy & Data Protection, Intuitive Surgical, about why HIPAA must be considered within the scope of M&A due diligence and what the diligence process looks like. They discuss documentation, external data sources, the diligence call, and practices to review, such as de-identified Protected Health Information and web tracking technologies. Vanessa and Wendy spoke on an AHLA webinar last year related to this topic. Sponsored by Clearwater.

To learn more about AHLA and the educational resources available to the health law community, visit americanhealthlaw.org.

Related Blogs

Clear Perspective: The Truth about EDR Killers

Clear Perspective: The Truth about EDR Killers

In this episode, we discuss the critical role of Endpoint Detection and Response (EDR) systems in cybersecurity, particularly in healthcare. We explore the concept of 'EDR killers'—malicious software designed to disable EDR solutions—and the conditions that make these attacks successful.

Connect
With Us